Bayer achieves strong Q1 gains but pharma sales drop
This article was originally published in Scrip
Executive Summary
Germany's chemicals and pharmaceuticals giant Bayer reported a strong first quarter with net income up by 63% to €693 million, driven by a turnaround in its material science division. However, its pharmaceutical unit showed a 2% drop in sales.